---
title: chronicÂ myelogenousÂ leukemiaÂ (CML)
alias: CML
date: "2023-01-22"
enableToc: false
---

> [!info]
>
> ðŸŒ± ä¾†è‡ª: [[leukemia]] and [[myeloproliferative neoplasms]]

# chronicÂ myelogenousÂ leukemiaÂ (CML)

## Epidemiology

- Myeloproliferative Neoplasm (MPN)
- 15-20% of adult leukemias,
- approx 5000 new cases/year in the United States, 1-2 cases per 100000 adults, median age 55-60
- è¡€ç´°èƒžæ¸›å°‘
- éª¨é«“ç™¼è‚² âœ– ä¸è‰¯
- æŒçºŒæ€§å¤–å‘¨è¡€::å–®æ ¸ç´°èƒž::å¢žå¤š
- è€å¹´ç”·æ€§

## Dx

- persistent (> 3 months) peripheral blood

  - monocytosis (> 1 Ã— 109/L and > 10% of differential)

- [[definition of chronic myelogenous leukemia (CML)]]
- [[epidemiology and risk factors of chronic myelogenous leukemia (CML)]]
- [[disease classification and manifestations of chronic myelogenous leukemia (CML)]]
- [[diagnostic evaluation of chronic myelogenous leukemia (CML)]]
- [[biology of chronic myelogenous leukemia (CML)]]
- [[treatment of chronic myelogenous leukemia (CML)]]
- [[prognosis of chronic myelogenous leukemia (CML)]]

## REF

> Lancet2021;398:1914

> Nabhan C, Rosen ST. Chronic Lymphocytic Leukemia: A Clinical Review. JAMA. 2014;312(21):2265. doi:10.1001/jama.2014.14553
